Aslam S, Mehra MR. COVID-19: Yet another coronavirus challenge in transplantation. J Heart Lung Transplant. 2020; 39:(5)408-409

Bhorade SM, Stern E. Immunosuppression for lung transplantation. Proc Am Thorac Soc. 2009; 6:(1)47-53

How to create real, lasting change after COVID-19. 2020. (accessed 10 August 2021)

Centers for Disease Control and Prevention. Underlying medical conditions associated with high risk for severe COVID-19: information for healthcare providers. 2021. (accessed 10 August 2021)

Department of Health, Health Service Executive. Guidance on cocooning to protect people over 70 years and those extremely medically vulnerable from COVID-19. Updated guidance from 29 June. 2021. (accessed 10 August 2021)

European Centre for Disease Prevention and Control. Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK: seventh update. 2020. (accessed 10 August 2021)

SI No 98/2020: Medicinal products (prescriptions and control of supply) (amendment) regulations 2020. 2020. (accessed 10 August 2021)

Health Protection Surveillance Centre. Epidemiology of COVID-19 March 2020. 2020. (accessed 10 August 2021)

Health Service Executive. Procedure for the management of virtual outpatient clinics. 2020. (accessed 10 August 2021)

Holm AM, Mehra MR, Courtwright A Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement. J Heart Lung Transplant. 2020; 39:(7)619-626

International Registry in Organ Donation and Transplantation. Preliminary numbers 2019. 2020. (accessed 10 August 2021)

Johns Hopkins Coronavirus Resource Center. COVID-19 data in motion. 2021. (accessed 10 August 2021)

Lesko MB, Rudym D, Kon Z Telehealth and home monitoring in lung transplant. Journal of Heart and Lung Transplant. 2020; 39

McDermott JK, Girgis RE. Individualizing immunosuppression in lung transplantation. Glob Cardiol Sci Pract. 2018; 2018:(1)

Organ Donation Transplant Ireland. Annual report 2019. 2019. (accessed 10 August 2021)

Pereira MR, Mohan S, Cohen DJ COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 2020; 20:(7)1800-1808

Sidhu A, Chaparro C, Chow CW, Davies M, Singer LG. Outcomes of telehealth care for lung transplant recipients. Clin Transplant. 2019; 33:(6)

Snell GI, Paraskeva MA, Levvey BJ, Westall GP. Immunosuppression for lung transplant recipients. Current Respiratory Care Reports. 2014; 3:(3)88-95

Verity R, Okell LC, Dorigatti I Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20:(6)669-677

Weill D. Lung transplantation: indications and contraindications. J Thorac Dis. 2018; 10:(7)4574-4587

Weill D, Benden C, Corris PA A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015; 34:(1)1-15

World Health Organization. Timeline: WHO's COVID-19 response. 2021. (accessed 10 August 2021)

Providing post-lung transplant care during the time of COVID-19

09 September 2021
Volume 30 · Issue 16


The COVID-19 pandemic is a public health emergency of international concern. Solid organ transplant recipients have been identified as being at high risk of acquiring the virus SARS-CoV-2 and having a more severe COVID-19 disease. This article describes the experience of the National Lung Transplant Centre in Ireland in changing established care pathways for lung transplant recipients during the pandemic. The innovations which were put in place to protect this clinically vulnerable group are discussed. With the advancement of technology and remote monitoring systems available, patient-focused strategies and community-based interventions were implemented. Additional strategies have been implemented so that the new model of care can be safely maintained.

The novel coronavirus caused by the virus SARS-CoV-2, since named coronavirus disease 2019 (COVID-19) emerged in the Hubei province of China in early December 2019 and spread worldwide. As the number of cases and deaths attributed to this disease increased, COVID-19 was declared a ‘public health emergency of international concern’ by the World Health Organization (WHO) on 30 January 2020 (WHO, 2021).

As of 14 June 2020, the estimated total global deaths from COVID-19 had surpassed 420 000. As BJN went to press, this number had risen to 4 307 242 (Johns Hopkins Coronavirus Resource Center, 2021). Information from international healthcare centres, including the Centers for Disease Control and Prevention (CDC), in the USA, was reviewed to assess the risk to transplant patients of acquiring SARS-CoV-2 and of developing severe disease (CDC, 2021). The CDC, among others, identified those people at a higher risk of severe illness, including older adults, people of any age with serious underlying medical conditions and solid organ transplant recipients. Lung transplant recipients were therefore felt to be at higher risk for acquiring SARS-CoV-2 and having more severe COVID-19 disease (Aslam and Mehra, 2020; Pereira et al, 2020).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content